Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase

Ke-Qi Hu1, Xiang-Sheng Ao1

  • 1Department of Neurosurgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, China.

Abstract

Insights

Long non-coding RNA DLGAP1-AS1 promotes glioma progression by sponging miR-628-5p, leading to increased DDX59 expression. This axis is a potential therapeutic target for glioma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Abnormal expression of long non-coding RNAs (lncRNAs) is implicated in glioma progression.
  • The specific role of lncRNA DLGAP1 antisense RNA 1 (DLGAP1-AS1) in glioma remains largely uncharacterized.

Purpose of the Study:

  • To investigate the biological function and mechanism of DLGAP1-AS1 in glioma.
  • To elucidate the regulatory pathway involving DLGAP1-AS1, miR-628-5p, and DDX59 in glioma.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) assays (CCK-8, EdU, Transwell, Western blot).
  • Dual-luciferase reporter gene assay to confirm molecular interactions.

Main Results:

  • DLGAP1-AS1 expression is upregulated in higher-grade gliomas and correlates with shorter survival.
  • DLGAP1-AS1 enhances glioma cell proliferation, migration, invasion, and EMT.
  • DLGAP1-AS1 acts as a molecular sponge for miR-628-5p, and this interaction upregulates DEAD-box helicase 59 (DDX59) expression.

Conclusions:

  • The DLGAP1-AS1/miR-628-5p/DDX59 axis is a key regulator of glioma progression.
  • DLGAP1-AS1 promotes glioma development, partly through the miR-628-5p/DDX59 pathway.
  • Targeting this axis may offer a novel therapeutic strategy for glioma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K